Linked Data API

Show Search Form

Search Results

829014
registered interest false more like this
date less than 2018-01-23more like thismore than 2018-01-23
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Radioisotopes: Imports remove filter
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what steps they are taking to ensure that the UK radiopharmaceutical supply after leaving Euratom might be relied upon to not have an impact on patients, in terms of (1) timeliness of delivery, and (2) the quantity supplied of radiopharmaceutical supplies produced (a) in the EU, and (b) outside the EU. more like this
tabling member printed
Lord Carlile of Berriew more like this
uin HL4999 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-02-01more like thismore than 2018-02-01
answer text <p>The Government is fully aware of the importance of medical radioisotopes and the reliance on nuclear medicine for diagnostic procedures in the National Health Service. The United Kingdom’s ability to import medical isotopes from Europe and the rest of the world will not be affected by withdrawal from Euratom. It is in the interest of both the UK and European Union to avoid disruption in the timely access of treatment to patients; and to ensure that cross-border trade with the EU is frictionless as possible. This will be part of the broader negotiations of the UK’s future relations with the EU.</p><p> </p> more like this
answering member printed Lord O'Shaughnessy more like this
question first answered
remove filter
answering member
4545
label Biography information for Lord O'Shaughnessy more like this
tabling member
1138
label Biography information for Lord Carlile of Berriew more like this